AAAAAA

   
Results: 1-22 |
Results: 22
IMPACT OF RECIPIENT CMV STATUS ON OUTCOME AFTER T-DEPLETED VUD TRANSPLANTATION FOR CML
Authors: CRADDOCK C SZYDLO RM WARD K YONG A KANFER E APPERLEY J GOLDMAN JM
Citation: C. Craddock et al., IMPACT OF RECIPIENT CMV STATUS ON OUTCOME AFTER T-DEPLETED VUD TRANSPLANTATION FOR CML, Bone marrow transplantation, 21, 1998, pp. 120-120
BMT FOR CHRONIC MYELOID-LEUKEMIA (CML) - A MULTIVARIATE STUDY TO DETERMINE PROGNOSTIC FACTORS FOR SURVIVAL BEYOND THE FIRST YEAR
Authors: SZYDLO RM SAVAGE DG GOLDMAN JM
Citation: Rm. Szydlo et al., BMT FOR CHRONIC MYELOID-LEUKEMIA (CML) - A MULTIVARIATE STUDY TO DETERMINE PROGNOSTIC FACTORS FOR SURVIVAL BEYOND THE FIRST YEAR, Bone marrow transplantation, 21, 1998, pp. 301-301
CYTOGENETIC STATUS PRETRANSPLANT AS A PREDICTOR OF OUTCOME POST BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)
Authors: KONSTANTINIDOU P SZYDLO RM CHASE A GOLDMAN JM
Citation: P. Konstantinidou et al., CYTOGENETIC STATUS PRETRANSPLANT AS A PREDICTOR OF OUTCOME POST BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML), Bone marrow transplantation, 21, 1998, pp. 302-302
TRANSPLANT-RELATED MORTALITY (TRM) FOLLOWING ALLOGENEIC BMT FOR CHRONIC MYELOID-LEUKEMIA (CML) PATIENTS AGED OVER 45
Authors: CAPELLI D SZYDLO RM SAVAGE DG APPERLEY J GOLDMAN JM
Citation: D. Capelli et al., TRANSPLANT-RELATED MORTALITY (TRM) FOLLOWING ALLOGENEIC BMT FOR CHRONIC MYELOID-LEUKEMIA (CML) PATIENTS AGED OVER 45, Bone marrow transplantation, 21, 1998, pp. 303-303
A COMPARISON OF PROPHYLACTIC VERSUS PREEMPTIVE GANCICLOVIR TO PREVENTCYTOMEGALOVIRUS (CMV) DISEASE AFTER VOLUNTEER UNRELATED DONOR (VUD) BONE-MARROW TRANSPLANT (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML)
Authors: STOCCHI R SZYDLO RM CRADDOCK C WARD KN APPERLEY JF GOLDMAN JM
Citation: R. Stocchi et al., A COMPARISON OF PROPHYLACTIC VERSUS PREEMPTIVE GANCICLOVIR TO PREVENTCYTOMEGALOVIRUS (CMV) DISEASE AFTER VOLUNTEER UNRELATED DONOR (VUD) BONE-MARROW TRANSPLANT (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML), Bone marrow transplantation, 21, 1998, pp. 488-488
PROGNOSTIC FACTORS INFLUENCING EARLY TRANSPLANT-RELATED MORTALITY (TRM) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH HLA-IDENTICAL SIBLING DONORS FOR CHRONIC MYELOID-LEUKEMIA (CML)
Authors: CAPELLI D SZYDLO RM SAVAGE DG APPERLEY JF GOLDMAN JW
Citation: D. Capelli et al., PROGNOSTIC FACTORS INFLUENCING EARLY TRANSPLANT-RELATED MORTALITY (TRM) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH HLA-IDENTICAL SIBLING DONORS FOR CHRONIC MYELOID-LEUKEMIA (CML), British Journal of Haematology, 102(1), 1998, pp. 318-318
BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE EFFECTS OF DIFFERING CRITERIA FOR DEFINING CHRONIC PHASE ON PROBABILITIES OFSURVIVAL AND RELAPSE
Authors: SZYDLO RM SAVAGE DG GOLDMAN JM
Citation: Rm. Szydlo et al., BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE EFFECTS OF DIFFERING CRITERIA FOR DEFINING CHRONIC PHASE ON PROBABILITIES OFSURVIVAL AND RELAPSE, Experimental hematology, 25(8), 1997, pp. 490-490
LONG-TERM RESULTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - A REPORT FROM THE CHRONIC LEUKEMIA WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION
Authors: VANRHEE F SZYDLO RM HERMANS J DEVERGIE A FRASSONI F ARCESE W DEWITTE T KOLB HJ NIEDERWISER D JACOBSEN N GAHRTON G BANDINI G CARRERAS E BACIGALUPO A MICHALLET M RUUTU T REIFFERS J GOLDMAN JM APPERLEY J GRATWOHL A
Citation: F. Vanrhee et al., LONG-TERM RESULTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - A REPORT FROM THE CHRONIC LEUKEMIA WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION, Bone marrow transplantation, 20(7), 1997, pp. 553-560
PARANASAL SINUSITIS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT
Authors: SAVAGE DG TAYLOR P BLACKWELL J CHEN F SZYDLO RM RULE SAJ SPENCER A APPERLEY JF GOLDMAN JM
Citation: Dg. Savage et al., PARANASAL SINUSITIS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT, Bone marrow transplantation, 19(1), 1997, pp. 55-59
THE RATE AND KINETICS OF MOLECULAR RESPONSE TO DONOR LEUKOCYTE TRANSFUSIONS IN CHRONIC MYELOID-LEUKEMIA PATIENTS TREATED FOR RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: RAANANI P DAZZI F SOHAL J SZYDLO RM VANRHEE F REITER A LIN F GOLDMAN JM CROSS NCP
Citation: P. Raanani et al., THE RATE AND KINETICS OF MOLECULAR RESPONSE TO DONOR LEUKOCYTE TRANSFUSIONS IN CHRONIC MYELOID-LEUKEMIA PATIENTS TREATED FOR RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, British Journal of Haematology, 99(4), 1997, pp. 945-950
BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE EFFECTS OF DIFFERING CRITERIA FOR DEFINING CHRONIC PHASE ON PROBABILITIES OFSURVIVAL AND RELAPSE
Authors: SAVAGE DG SZYDLO RM CHASE A APPERLEY JF GOLDMAN JM
Citation: Dg. Savage et al., BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE EFFECTS OF DIFFERING CRITERIA FOR DEFINING CHRONIC PHASE ON PROBABILITIES OFSURVIVAL AND RELAPSE, British Journal of Haematology, 99(1), 1997, pp. 30-35
CLINICAL-FEATURES AT DIAGNOSIS IN 430 PATIENTS WITH CHRONIC MYELOID-LEUKEMIA SEEN AT A REFERRAL CENTER OVER A 16-YEAR PERIOD
Authors: SAVAGE DG SZYDLO RM GOLDMAN JM
Citation: Dg. Savage et al., CLINICAL-FEATURES AT DIAGNOSIS IN 430 PATIENTS WITH CHRONIC MYELOID-LEUKEMIA SEEN AT A REFERRAL CENTER OVER A 16-YEAR PERIOD, British Journal of Haematology, 96(1), 1997, pp. 111-116
BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA IN PATIENTS OVER 45 YRS OF AGE - A MULTIVARIATE STUDY TO DETERMINE PROGNOSTIC FACTORS FOR SURVIVAL
Authors: CAPELLI D SZYDLO RM SAVAGE DG APPERLEY J GOLDMAN JM
Citation: D. Capelli et al., BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA IN PATIENTS OVER 45 YRS OF AGE - A MULTIVARIATE STUDY TO DETERMINE PROGNOSTIC FACTORS FOR SURVIVAL, Blood, 90(10), 1997, pp. 1007-1007
THE INCIDENCE, KINETICS AND DURABILITY OF RESPONSE TO DONOR LEUKOCYTETRANSFUSIONS FOR CML PATIENTS WHO RELAPSE AFTER BMT
Authors: RAANANI P DAZZI F SOHAL J SZYDLO RM VANRHEE F REITER A LIN F APPERLEY JF GOLDMAN JM CROSS NCP
Citation: P. Raanani et al., THE INCIDENCE, KINETICS AND DURABILITY OF RESPONSE TO DONOR LEUKOCYTETRANSFUSIONS FOR CML PATIENTS WHO RELAPSE AFTER BMT, Blood, 90(10), 1997, pp. 2443-2443
QUANTIFICATION OF RESIDUAL DISEASE IN PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA - COMPARISON OF BLOOD AND BONE-MARROW
Authors: VANRHEE F MARKS DI LIN F SZYDLO RM HOCHHAUS A TRELEAVEN J DELORD C CROSS NCP GOLDMAN JM
Citation: F. Vanrhee et al., QUANTIFICATION OF RESIDUAL DISEASE IN PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA - COMPARISON OF BLOOD AND BONE-MARROW, Leukemia, 9(2), 1995, pp. 329-335
IN-VITRO CYTOKINE PROFILES AND THEIR RELEVANCE TO REJECTION FOLLOWINGRENAL-TRANSPLANTATION
Authors: KAMINSKI ER KAMINSKI A BENDING MR CHANG R HEADS A SZYDLO RM PEREIRA RS
Citation: Er. Kaminski et al., IN-VITRO CYTOKINE PROFILES AND THEIR RELEVANCE TO REJECTION FOLLOWINGRENAL-TRANSPLANTATION, Transplantation, 60(7), 1995, pp. 703-706
CYTOTOXIC T-LYMPHOCYTE PRECURSOR FREQUENCY ANALYSES IN BONE-MARROW TRANSPLANTATION WITH VOLUNTEER UNRELATED DONORS - VALUE IN DONOR SELECTION
Authors: SPENCER A BROOKES PA KAMINSKI E HOWS JM SZYDLO RM VANRHEE F GOLDMAN JM BATCHELOR JR
Citation: A. Spencer et al., CYTOTOXIC T-LYMPHOCYTE PRECURSOR FREQUENCY ANALYSES IN BONE-MARROW TRANSPLANTATION WITH VOLUNTEER UNRELATED DONORS - VALUE IN DONOR SELECTION, Transplantation, 59(9), 1995, pp. 1302-1308
BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA WITH VOLUNTEER UNRELATED DONORS USING EX-VIVO OR IN-VIVO T-CELL DEPLETION - MAJOR PROGNOSTIC IMPACT OF HLA CLASS-I IDENTITY BETWEEN DONOR AND RECIPIENT
Authors: SPENCER A SZYDLO RM BROOKES PA KAMINSKI E RULE S VANRHEE F WARD KN HALE G WALDMANN H HOWS JM BATCHELOR JR GOLDMAN JM
Citation: A. Spencer et al., BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA WITH VOLUNTEER UNRELATED DONORS USING EX-VIVO OR IN-VIVO T-CELL DEPLETION - MAJOR PROGNOSTIC IMPACT OF HLA CLASS-I IDENTITY BETWEEN DONOR AND RECIPIENT, Blood, 86(9), 1995, pp. 3590-3597
PROGNOSTIC VARIABLES IN SIBLING BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: SAVAGE DG SZYDLO RM CHASE A GOLDMAN JM
Citation: Dg. Savage et al., PROGNOSTIC VARIABLES IN SIBLING BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, Blood, 86(10), 1995, pp. 375-375
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA (CML) IN FIRST-CHRONIC PHASE - INCREASED INCIDENCE OF LATE RELAPSE WITHMALE DONORS
Authors: VANRHEE F SZYDLO RM GRATWOHL A HERMANS J ARCESE W DEWITTE T GOLDMAN JM
Citation: F. Vanrhee et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA (CML) IN FIRST-CHRONIC PHASE - INCREASED INCIDENCE OF LATE RELAPSE WITHMALE DONORS, Experimental hematology, 22(8), 1994, pp. 692-692
CYTOTOXIC T-LYMPHOCYTE PRECURSOR (CTLP) FREQUENCY PREDICTS OUTCOME INVOLUNTEER UNRELATED DONOR BMT FOR CHRONIC PHASE CML
Authors: SPENCER A KAMINSKI ER HOWS JM BROOKES PA SZYDLO RM BATCHELOR JR GOLDMAN JM
Citation: A. Spencer et al., CYTOTOXIC T-LYMPHOCYTE PRECURSOR (CTLP) FREQUENCY PREDICTS OUTCOME INVOLUNTEER UNRELATED DONOR BMT FOR CHRONIC PHASE CML, Experimental hematology, 22(8), 1994, pp. 715-715
DETECTION OF RESIDUAL LEUKEMIA MORE THAN 10 YEARS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: VANRHEE F LIN F CROSS NCP REID CDL LAKHANI AKV SZYDLO RM GOLDMAN JM
Citation: F. Vanrhee et al., DETECTION OF RESIDUAL LEUKEMIA MORE THAN 10 YEARS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, Bone marrow transplantation, 14(4), 1994, pp. 609-612
Risultati: 1-22 |